Literature DB >> 18375968

Electrical storm in a patient with arrhythmogenic right ventricular cardiomyopathy and SCN5A mutation.

Damir Erkapic1, Thomas Neumann, Jörn Schmitt, Johannes Sperzel, Alexander Berkowitsch, Malte Kuniss, Christian W Hamm, Heinz-Friedrich Pitschner.   

Abstract

We described a case of a 58-year-old man with organic changes consistent with right ventricular cardiomyopathy. He also had a loss-of-function mutation in the cardiac sodium channel gene SCN5A, described in Brugada syndrome. He first presented with non-sustained ventricular tachycardia and was implanted with an implantable cardioverter defibrillator. He remained asymptomatic for 8 years until he developed recurrent episodes of ventricular tachyarrhythmias, which required multiple shocks. The patient was treated with a combination of quinidine and verapamil and since then remained free of arrhythmias.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18375968     DOI: 10.1093/europace/eun065

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  9 in total

Review 1.  Clinical interpretation of genetic variants in arrhythmogenic right ventricular cardiomyopathy.

Authors:  Mireia Alcalde; Oscar Campuzano; Georgia Sarquella-Brugada; Elena Arbelo; Catarina Allegue; Sara Partemi; Anna Iglesias; Antonio Oliva; Josep Brugada; Ramon Brugada
Journal:  Clin Res Cardiol       Date:  2014-11-15       Impact factor: 5.460

2.  SCN5A mutation in Chinese patients with arrhythmogenic right ventricular dysplasia.

Authors:  J Yu; J Hu; X Dai; Q Cao; Q Xiong; X Liu; X Liu; Y Shen; Q Chen; W Hua; K Hong
Journal:  Herz       Date:  2013-12-08       Impact factor: 1.443

3.  Epsilon-like electrocardiographic pattern in a patient with Brugada syndrome.

Authors:  Ozcan Ozeke; Umut Y Cavus; Ilyas Atar; Bulent Ozin; Erdogan Ilkay
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-07       Impact factor: 1.468

4.  Verapamil reduces incidence of reentry during ventricular fibrillation in pigs.

Authors:  Qi Jin; Derek J Dosdall; Li Li; Jack M Rogers; Raymond E Ideker; Jian Huang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-08-29       Impact factor: 4.733

Review 5.  The genetic background of arrhythmogenic right ventricular cardiomyopathy.

Authors:  Seiko Ohno
Journal:  J Arrhythm       Date:  2016-02-26

Review 6.  Sudden cardiac death: focus on the genetics of channelopathies and cardiomyopathies.

Authors:  Simona Magi; Vincenzo Lariccia; Marta Maiolino; Salvatore Amoroso; Santo Gratteri
Journal:  J Biomed Sci       Date:  2017-08-15       Impact factor: 8.410

Review 7.  Calcium as a Key Player in Arrhythmogenic Cardiomyopathy: Adhesion Disorder or Intracellular Alteration?

Authors:  Francesco Moccia; Francesco Lodola; Ilaria Stadiotti; Chiara Assunta Pilato; Milena Bellin; Stefano Carugo; Giulio Pompilio; Elena Sommariva; Angela Serena Maione
Journal:  Int J Mol Sci       Date:  2019-08-16       Impact factor: 5.923

Review 8.  Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies.

Authors:  Andreas Brodehl; Hans Ebbinghaus; Marcus-André Deutsch; Jan Gummert; Anna Gärtner; Sandra Ratnavadivel; Hendrik Milting
Journal:  Int J Mol Sci       Date:  2019-09-06       Impact factor: 5.923

Review 9.  Arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC/D) in clinical practice.

Authors:  Ka Hou Christien Li; George Bazoukis; Tong Liu; Guangping Li; William K K Wu; Sunny Hei Wong; Wing Tak Wong; Yat Sun Chan; Martin C S Wong; Katharina Wassilew; Vassilios S Vassiliou; Gary Tse
Journal:  J Arrhythm       Date:  2017-12-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.